We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of XENT yet.

XENT Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2022, worth a combined $0 — down 100% from $826M a quarter earlier.

Sellers outnumbered buyers: 126 funds closed out of XENT and 0 opened new positions — a net loss of 126 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Versor Investments, exiting entirely with an estimated $93.1M sold.

  • 0 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2022, down from 131 in Q1 2022.
  • Funds reported $0 of Intersect ENT, Inc stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Intersect ENT, Inc positions in Q2 2022 and 126 closed out, a net change of -126 holders.
  • The largest Intersect ENT, Inc seller in Q2 2022 was Versor Investments, an estimated $93.1M sold.

Based on aggregated 13F filings for Q2 2022.